Compare TBI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBI | LAB |
|---|---|---|
| Founded | 1985 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.4M | 326.2M |
| IPO Year | 1995 | 2008 |
| Metric | TBI | LAB |
|---|---|---|
| Price | $10.73 | $0.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $6.00 | $1.35 |
| AVG Volume (30 Days) | 308.8K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.39 | ★ 61.54 |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | $6.25 | N/A |
| Revenue Next Year | $3.90 | $2.63 |
| P/E Ratio | ★ N/A | $2.51 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.18 | $0.63 |
| 52 Week High | $11.03 | $1.72 |
| Indicator | TBI | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 65.10 | 34.67 |
| Support Level | $4.57 | $0.63 |
| Resistance Level | $10.88 | $1.02 |
| Average True Range (ATR) | 0.39 | 0.04 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 77.05 | 13.30 |
TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.